Cite
HARVARD Citation
Tapper, E. et al. (2017). Real‐world effectiveness for 12 weeks of ledipasvir–sofosbuvir for genotype 1 hepatitis C: the Trio Health study. Journal of viral hepatitis. 24 (1), pp. 22-27. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tapper, E. et al. (2017). Real‐world effectiveness for 12 weeks of ledipasvir–sofosbuvir for genotype 1 hepatitis C: the Trio Health study. Journal of viral hepatitis. 24 (1), pp. 22-27. [Online].